FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

398708002: Product containing neomycin sulfate and polymyxin B sulfate and prednisolone acetate (medicinal product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    3523343010 Product containing neomycin sulfate and polymyxin B sulfate and prednisolone acetate (medicinal product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    3523345015 Product containing neomycin sulfate and polymyxin B sulfate and prednisolone acetate en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    3695214011 Neomycin sulfate and polymyxin B sulfate and prednisolone acetate product en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    3840831000005114 neomycinsulfat + polymyxin B-sulfat + prednisolonacetat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    neomycinsulfat + polymyxin B-sulfat + prednisolonacetat Is a Product containing neomycin (medicinal product) false Inferred relationship Some
    neomycinsulfat + polymyxin B-sulfat + prednisolonacetat Is a Product containing polymyxin B (medicinal product) false Inferred relationship Some
    neomycinsulfat + polymyxin B-sulfat + prednisolonacetat Is a Product containing prednisolone (medicinal product) false Inferred relationship Some
    neomycinsulfat + polymyxin B-sulfat + prednisolonacetat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Corticosterone false Inferred relationship Some
    neomycinsulfat + polymyxin B-sulfat + prednisolonacetat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Prednisolone acetate false Inferred relationship Some
    neomycinsulfat + polymyxin B-sulfat + prednisolonacetat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Polymyxin B sulfate false Inferred relationship Some
    neomycinsulfat + polymyxin B-sulfat + prednisolonacetat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Antiinfektiøst middel til huden false Inferred relationship Some
    neomycinsulfat + polymyxin B-sulfat + prednisolonacetat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Neomycin sulfate false Inferred relationship Some
    neomycinsulfat + polymyxin B-sulfat + prednisolonacetat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. binyrehormonmiddel false Inferred relationship Some
    neomycinsulfat + polymyxin B-sulfat + prednisolonacetat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. glucocorticoidhormon false Inferred relationship Some
    neomycinsulfat + polymyxin B-sulfat + prednisolonacetat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Baktericid false Inferred relationship Some
    neomycinsulfat + polymyxin B-sulfat + prednisolonacetat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Local anti-infective false Inferred relationship Some
    neomycinsulfat + polymyxin B-sulfat + prednisolonacetat Is a Product containing neomycin in ophthalmic dosage form false Inferred relationship Some
    neomycinsulfat + polymyxin B-sulfat + prednisolonacetat Is a Product containing polymyxin B in ophthalmic dosage form false Inferred relationship Some
    neomycinsulfat + polymyxin B-sulfat + prednisolonacetat Is a Product containing prednisolone in ocular dose form (medicinal product form) false Inferred relationship Some
    neomycinsulfat + polymyxin B-sulfat + prednisolonacetat Has manufactured dose form Ocular dose form (dose form) false Inferred relationship Some
    neomycinsulfat + polymyxin B-sulfat + prednisolonacetat Is a Product containing neomycin and prednisolone (medicinal product) false Inferred relationship Some
    neomycinsulfat + polymyxin B-sulfat + prednisolonacetat Is a Product containing neomycin and polymyxin B (medicinal product) false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    neomycinsulfat + polymyxin B-sulfat + prednisolonacetat 0,35 %/10.000 enheder/0,5 % wt/vol suspension Is a False neomycinsulfat + polymyxin B-sulfat + prednisolonacetat Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start